Have a feature idea you'd love to see implemented?
Let us know!
XOMA XOMA Corp
Price (delayed)
$30.07
Market cap
$354.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.44
Enterprise value
$331.12M
XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company's portfolio of partner-funded programs spans multiple stages
Highlights
The revenue has grown by 42% from the previous quarter
XOMA's gross profit has increased by 42% from the previous quarter
The company's quick ratio has surged by 109% YoY but it fell by 13% QoQ
XOMA's net income has shrunk by 60% QoQ and by 12% YoY
The EPS has contracted by 40% from the previous quarter and by 22% YoY
Key stats
What are the main financial stats of XOMA
Market
Valuations
Earnings
Shares outstanding
11.78M
Market cap
$354.31M
Enterprise value
$331.12M
Price to book (P/B)
4.15
Price to sales (P/S)
16.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.33
Revenue
$21.61M
EBIT
-$20.32M
EBITDA
-$20.03M
Free cash flow
-$20.02M
Per share
Balance sheet
Liquidity
EPS
-$3.44
Free cash flow per share
-$1.71
Book value per share
$7.25
Revenue per share
$1.84
TBVPS
$19.07
Total assets
$223.34M
Total liabilities
$138.53M
Debt
$118.94M
Equity
$84.81M
Working capital
$137.89M
Debt to equity
1.4
Current ratio
7.52
Quick ratio
6.81
Net debt/EBITDA
1.16
Margins
Efficiency
Dividend
EBITDA margin
-92.7%
Gross margin
100%
Net margin
-145%
Operating margin
-243.7%
Return on assets
-14.8%
Return on equity
-38.3%
Return on invested capital
-10.7%
Return on capital employed
-10%
Return on sales
-94%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XOMA stock price
How has the XOMA stock price performed over time
Intraday
0.17%
1 week
0.64%
1 month
5.66%
1 year
91.28%
YTD
62.54%
QTD
13.56%
Financial performance
How have XOMA's revenue and profit performed over time
Revenue
$21.61M
Gross profit
$21.61M
Operating income
-$52.66M
Net income
-$31.33M
Gross margin
100%
Net margin
-145%
The operating income has plunged by 87% YoY and by 23% from the previous quarter
The net margin has surged by 77% year-on-year but it has declined by 13% since the previous quarter
XOMA's operating margin has soared by 62% YoY and by 13% from the previous quarter
XOMA's net income has shrunk by 60% QoQ and by 12% YoY
Growth
What is XOMA's growth rate over time
Valuation
What is XOMA stock price valuation
P/E
N/A
P/B
4.15
P/S
16.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.33
The EPS has contracted by 40% from the previous quarter and by 22% YoY
XOMA's price to book (P/B) is 34% more than its last 4 quarters average of 3.1 and 26% more than its 5-year quarterly average of 3.3
The company's equity fell by 20% YoY and by 15% QoQ
The stock's P/S is 48% below its last 4 quarters average of 31.2 and 40% below its 5-year quarterly average of 27.3
The revenue has grown by 42% from the previous quarter
Efficiency
How efficient is XOMA business performance
The ROS has soared by 85% YoY but it has contracted by 19% from the previous quarter
The company's return on invested capital has surged by 75% YoY but it fell by 43% QoQ
XOMA's ROE has plunged by 62% from the previous quarter and by 41% YoY
The return on assets has increased by 37% year-on-year but it has declined by 36% since the previous quarter
Dividends
What is XOMA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for XOMA.
Financial health
How did XOMA financials performed over time
XOMA's total assets is 61% greater than its total liabilities
XOMA's current ratio has surged by 125% year-on-year but it is down by 14% since the previous quarter
The company's quick ratio has surged by 109% YoY but it fell by 13% QoQ
The debt is 40% greater than the equity
The company's equity fell by 20% YoY and by 15% QoQ
The company's debt to equity rose by 15% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.